SNARE-dependent glutamate release in megakaryocytes

Area of Science:

• Hematology
• Neuroscience
• Cell Biology

Background:

• Megakaryocytopoiesis is crucial for treating blood disorders.
• Megakaryocytes express functional N-methyl-D-aspartate-type glutamate receptors.
• Understanding glutamate release mechanisms in megakaryocytes is vital for therapeutic development.

Purpose of the Study:

• To determine glutamate release capacity in megakaryocytes.
• To investigate the role of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins in vesicular glutamate release.
• To explore glutamate signaling as a potential therapeutic target for hematological disorders.

Main Methods:

• Utilized MEG-01 cell line, primary megakaryocytes, and bone marrow tissue.
• Employed reverse transcription polymerase chain reaction, Western blot, and immunolocalization.
• Assessed vesicle recycling and glutamate release using acridine orange, FM1-43 staining, and enzyme-linked fluorimetric assays.
• Examined genetically modified MEG-01 cells with altered SNARE and vesicular protein expression.

Main Results:

• Megakaryocytes express key proteins for vesicular glutamate release, including SNARE proteins (VAMP, SNAP-23, syntaxin) and glutamate transporters (VGLUT1, VGLUT2).
• Demonstrated active vesicle recycling and differentiation-dependent glutamate release.
• Vesicle-associated membrane protein deficiency reduced glutamate release by 30%, while VGLUT1 overexpression increased it 2.2-fold.

Conclusions:

• Glutamate release from megakaryocytes is SNARE-dependent and occurs via exocytosis.
• Glutamate release increases during megakaryocyte differentiation.
• Targeting glutamate signaling pathways may offer novel therapeutic strategies for thrombosis and other hematological disorders.